New: The FDA has expanded the approval for GSK’s vaccine to protect against respiratory syncytial virus, or RSV, authorizing ...

UCLA researchers estimate more than 52,000 Californians died early due to chronic exposure to particulate matter in wildfire ...

Cycle Pharmaceuticals has offered $8 per share to acquire Vanda Pharmaceuticals. Just a month back, the CDMO FuturePak ...

For many Americans, health care means going to a local primary care office. But the vast majority of clinical research is ...

Stephen Quake, head of science for the Chan Zuckerberg Initiative, is trying to get the scientific community to work together ...

Weight loss treatments have the potential to revolutionize health care in rich countries. They are driving a race among ...

In today's Pharmalittle roundup, we're reading about Eli Lilly's Alzheimer's drug, the GSK-Elsie deal, and more.

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we ...

The BIOSECURE Act is, for now, just that — a proposal. But the looming bill’s impact was clearly visible at this year’s BIO ...

A new Peterson Health Technology Institute report suggests virtual physical therapy solutions could reduce insurers' health ...

Officials, doctors, and advocates expressed outrage in response to STAT’s revelations that women with sickle cell disease ...

The FDA's vaccine advisory panel voted to recommend that this fall’s Covid-19 shots should be updated to target Omicron’s ...